11 – 20 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Drug exposure and subsequent diagnosis with ANCA-associated vasculitis – A population-based case- control study
2024) p.191-191(
- Contribution to conference › Abstract
-
Mark
The HLA region in ANCA-associated vasculitis : characterisation of genetic associations in a Scandinavian patient population
(
- Contribution to journal › Article
-
Mark
Myocardial infarction in a population-based cohort of patients with biopsy-confirmed giant cell arteritis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Thyroid disease in ANCA-associated vasculitis : a clinical and epidemiological study
(
- Contribution to journal › Article
-
Mark
Classification Criteria for ANCA Associated Vasculitis – Ready for Prime Time?
(
- Contribution to journal › Scientific review
-
Mark
Data-driven subclassification of ANCA-associated vasculitis : model-based clustering of a federated international cohort
(
- Contribution to journal › Article
-
Mark
Temporal artery biopsy in giant cell arteritis : clinical perspectives and histological patterns
(
- Contribution to journal › Article
- 2023
-
Mark
Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis : a prospective study
(
- Contribution to journal › Article
-
Mark
Protein Profiling in Presymptomatic Individuals Separates Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Proteinase 3–Antineutrophil Cytoplasmic Antibody Vasculitides
(
- Contribution to journal › Article
-
Mark
Traditional and Disease-Specific Risk Factors for Cardiovascular Events in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis : A Multinational Retrospective Study
(
- Contribution to journal › Article